SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 189.55+3.5%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (21993)6/9/1998 8:15:00 AM
From: Andreas Helke   of 32384
 
We have discussed some time ago about this potential or in the view of many investors real problem. I don't think that there are many biotech company that would have any problems to avoid profits by simple increasing their research and development spending a bit.

Increasing research and development for sensible projects increases the value of the company. But since investors are much more impressed by rising positive earnings than by an impressive pipeline it is a very good idea to let enough revenue go to the bottom line of the balance sheet. I think Ligand does a reasonable job in this regard. After all they are expected to become profitable one year earlier than previously expected.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext